Adaptive Biotechnologies Corp (ADPT)
4.37
-0.05
(-1.13%)
USD |
NASDAQ |
Nov 21, 16:00
4.57
+0.20
(+4.58%)
After-Hours: 20:00
Adaptive Biotechnologies Revenue (Quarterly): 46.44M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 46.44M |
| June 30, 2024 | 43.19M |
| March 31, 2024 | 41.87M |
| December 31, 2023 | 45.78M |
| September 30, 2023 | 37.92M |
| June 30, 2023 | 48.93M |
| March 31, 2023 | 37.65M |
| December 31, 2022 | 55.20M |
| September 30, 2022 | 47.83M |
| June 30, 2022 | 43.66M |
| March 31, 2022 | 38.62M |
| December 31, 2021 | 37.93M |
| September 30, 2021 | 39.47M |
| June 30, 2021 | 38.50M |
| Date | Value |
|---|---|
| March 31, 2021 | 38.44M |
| December 31, 2020 | 30.18M |
| September 30, 2020 | 26.30M |
| June 30, 2020 | 20.99M |
| March 31, 2020 | 20.91M |
| December 31, 2019 | 24.21M |
| September 30, 2019 | 26.06M |
| June 30, 2019 | 22.14M |
| March 31, 2019 | 12.67M |
| December 31, 2018 | 17.19M |
| September 30, 2018 | 17.19M |
| June 30, 2018 | 11.57M |
| March 31, 2018 | 9.715M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
20.91M
Minimum
Mar 2020
55.20M
Maximum
Dec 2022
38.20M
Average
38.56M
Median
Revenue (Quarterly) Benchmarks
| The Cooper Companies Inc | 1.003B |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.07M |
| Total Expenses (Quarterly) | 79.07M |
| EPS Diluted (Quarterly) | -0.22 |
| Enterprise Value | 401.39M |
| Gross Profit Margin (Quarterly) | 64.11% |
| Profit Margin (Quarterly) | -69.07% |
| Earnings Yield | -30.66% |
| Normalized Earnings Yield | -25.53 |